contact us

targetGroup_clinicianInnovators
targetGroup_ResearchAdministrator
targetGroup_IndustryPartner
targetGroup_Investor

Systemic Lupus Erythematosus (SLE) is an autoimmune condition which affects multiple organ systems, including skin, mouth, joints, kidneys, heart, lungs, intestine and blood. It is a relapsing-remitting disease with alternating disease-free and active periods; the active periods are known as flares, where active inflammation of organs and tissues takes place. Flares start subclinically (i.e. with increasing inflammation) and if untreated progress to clinical flares which manifest variously as rash, joint pains, low blood counts, seizures or blood/protein in the urine. All SLE patients are regularly monitored for development of flares as untreated clinical flares will result in organ damage and lead to irreversible damage, such as end stage kidney disease requiring lifelong dialysis.

In the current standard of care, there is an unmet medical need to detect patients with subclinical flares as existing markers of flares do not perform adequately.

Project Deliverables

A nanoparticle-based assay to detect subclinical flares in patients with SLE using tear samples, followed by validation in an SLE patient cohort.


Principal Investigator: Professor Julian Thumboo

Institution: Singapore General Hospital

NHIC Ref: NHIC-I2D-1604102

 

 

See all BIOPHARMA projects >

NEUROBROWSER™ — AN AUTOMATED EEG INTERPRETATION SYSTEM

Diagnosis and management of neurological disorders relies on visual review of electroencephalogra...

Modular Endoprosthesis for Mandible Reconstruction

Mandible defects may result from trauma, inflammatory diseases or upon tumour resection. The gold...

SERID™ — A Diagnostic-Therapeutic Device for the Eye

Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are the leading causes of bl...

Swellable Drug Loaded Stent Coating for Ureteral Stricture

Ureteric strictures result from fibrosis in the wall of the ureter, resulting in narrowing of the...

Novel inhibitors for Natural Killer/T-cell lymphoma (NKTCL)

The Natural Killer/T-cell lymphoma (NKTCL) is a subtype of Non-Hodgkin’s lymphoma (NHL) which is...

Biomarker for Rapid Diagnosis and Prediction of Severity of Acute Pneumonia

According to the World Health Organization, lower respiratory tract infections are the leading ca...

OUR PARTNERS

Clinical Partners


nhg logonuhs logosinghealth

 

Academic Partners


lkc medicalnus faculty of dentistrynus sphnus somduke nus

 

Supporting Partners


bms ipodxdipinmrcSCRIseriSMARTEnterpriseSG